Medacta Group SA

MOVE

CH0468525222

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 11:31:48 2023-12-01 am EST			5-day change	1st Jan Change
116.80 ^CHF	-0.85%		-0.85%	+13.40%

Nov. 30	Medacta to Expand Swiss Facilities to Boost Production Capacity	MT
Oct. 30	Medacta Group to Launch Optimized Knee Implant	MT

Presentation Operator MessageOperator (Operator)Good afternoon. This is the Chorus Call conference operator. Welco...

This article is reserved for subscribers

Signed up already?

Not subscribed yet?

Latest news about Medacta Group SA

Medacta to Expand Swiss Facilities to Boost Production Capacity	Nov. 30	MT
Medacta Group to Launch Optimized Knee Implant	Oct. 30	MT
Medacta's New Study Shows Accuracy of NextAR Shoulder Application	Oct. 13	MT
Transcript : Medacta Group SA, Q2 2023 Earnings Call, Sep 22, 2023	Sep. 22	CI
Medacta Group Reports Higher H1 Attributable Profit, Revenue	Sep. 22	MT
Medacta Group SA Reports Earnings Results for the Half Year Ended June 30, 2023	Sep. 20	CI
Transcript : Medacta Group SA, H1 2023 Sales/ Trading Statement Call, Jul 28, 2023	Jul. 28	CI
Medacta Posts 21% Increase in H1 Revenue; Raises FY23 Guidance	Jul. 28	MT
Medacta Group SA Announces Unaudited Revenue Results for the First Half Ended June 30, 2023	Jul. 28	CI
Medacta Group SA Updates Revenue Guidance for the Year 2023	Jul. 28	CI
Global markets live: Enel, ASML, Adobe, Nikola...	Jul. 05
Medacta Group Completes First MyPAO Surgery in Europe	Jul. 04	MT
Exclusive-EQT sounds out banks to manage LimaCorporate IPO - sources	May. 03	RE
Medacta Group SA Approves Distribution for the Year 2022	Apr. 27	CI
Medacta's MySpine Platform Shows Accuracy for Pedicle Screw Placement in Clinical Study	Mar. 21	MT
Medacta Group SA Provides Earnings Guidance for the Year 2023	Mar. 17	CI
Medacta Group SA Proposes Dividend	Mar. 17	CI
Transcript : Medacta Group SA, 2022 Earnings Call, Mar 17, 2023	Mar. 17	CI
Medacta Posts Lower FY22 Attributable Profit	Mar. 17	MT
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2022	Mar. 15	CI
Medacta Group SA Reports Earnings Results for the Full Year Ended December 31, 2022	Mar. 15	CI
Octavian Lifts Price Target on Medacta Group, Maintains Buy Recommendation	Feb. 06	MT
Transcript : Medacta Group SA, 2022 Earnings Call, Feb 03, 2023	Feb. 03	CI
Medacta's FY22 Revenue Soars 20% as Surgical Activities Normalize	Feb. 03	MT
Medacta Discloses First Surgeries in Japan Using Its Augmented Reality Surgical Platform	Jan. 10	MT

Medacta International SA is a Swiss-based company specialized in medical devices. The Company develops, manufactures and distributes orthopaedic and neurosurgical medical devices. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2023-12-05 - Stifel Medtech Orthopaedics Conference

More about the company

Income Statement Evolution

More financial data

Ratings for Medacta Group SA

Trading Rating :

Investor Rating :

ESG Refinitiv :

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

123.54EUR

Average target price

137.58EUR

Spread / Average Target

+11.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
MEDACTA GROUP SA	+13.40%	2 678 M $
ABBOTT LABORATORIES	-4.47%	182 B $
MEDTRONIC PLC	+2.92%	106 B $
BECTON, DICKINSON AND COMPANY	-6.31%	68 780 M $
DEXCOM, INC.	+2.98%	45 059 M $
CENCORA CORPORATION	+23.16%	40 616 M $
HOYA CORPORATION	+29.59%	39 198 M $
WEST PHARMACEUTICAL SERVICES, INC.	+49.48%	26 029 M $
ZIMMER BIOMET HOLDINGS, INC.	-7.47%	24 653 M $
METTLER-TOLEDO INTERNATIONAL, INC.	-23.59%	23 949 M $